Skip to content
SEKISUI XenoTech DD Blog Logo

ADME/PK & DDI Best Practices Industry Survey Results & Infographic

We recently ran an industry survey to help us understand what the current industry standards are for when and why researchers are running various Absorption, Distribution, Metabolism, and Excretion (ADME) studies, including Drug Metabolism and Pharmacokinetics (DMPK) and Drug-Drug Interaction (DDI) research. With over 3500 respondents, only 4% of respondents said they had never experienced any repercussions from postponing these studies.

Take a look at the infographic to read about when most researchers are performing ADME/PK & DDI testing, see what the top 4 repercussions and risks are from postponing, and the top 3 benefits to running more ADME testing during preclinical research. View the Infographic and Survey Results

About the Authors

Michael Millhollen received his bachelor's degree in Visual Communications from the University of Kansas and has over 20 years of experience in marketing and communications. As Global Marketing Manager, he is dedicated to the objective of sharing SEKISUI XenoTech’s scientific expertise and knowledge with scientists around the world.

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate